Kodiak Sciences (KOD) Interest Coverage Ratio (2017 - 2023)
Kodiak Sciences (KOD) reported Interest Coverage Ratio of 10900.0 for Q3 2023, up 45.14% on a YoY basis from 7509.88 in Q3 2022, and up 48.6% quarter-over-quarter from 21208.0 in Q2 2023.
Kodiak Sciences (KOD) Interest Coverage Ratio (2017 - 2023) Analysis & Trends
Kodiak Sciences has reported Interest Coverage Ratio for 7 years, with the latest figure at 10900.0 in Q3 2023.
- For the quarter ending Q3 2023, Interest Coverage Ratio rose 45.14% year-over-year to 10900.0; the trailing twelve-month figure through Jun 2024 stood at 42382.4 (down 116.66% YoY), and the FY2023 full-year result was 21332.38, down 12.48% from the prior year.
- Interest Coverage Ratio for Q3 2023 stood at 10900.0, up from 21208.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 2115.0 in Q1 2019, with the low at 21208.0 in Q2 2023.
- Historically, Interest Coverage Ratio has averaged 10951.32 across 5 years, with a median of 9663.17 in 2023.
- Annual changes were most pronounced in 2019 — Interest Coverage Ratio tumbled 116531.34% — and 2021, when it surged 60.27%.
- Kodiak Sciences' Interest Coverage Ratio stood at 6366.0 in 2019, then slipped by 22.64% to 7807.0 in 2020, then surged by 60.27% to 3101.63 in 2021, then sank by 496.99% to 18516.5 in 2022, then surged by 41.13% to 10900.0 in 2023.
- The last three Interest Coverage Ratio figures came in at 10900.0 (Q3 2023), 21208.0 (Q2 2023), and 18653.75 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -10,900.00 |
| Jun 30, 2023 | -21,208.00 |
| Mar 31, 2023 | -18,653.75 |
| Dec 31, 2022 | -18,516.50 |
| Sep 30, 2022 | -19,869.50 |
| Jun 30, 2022 | -18,413.60 |
| Mar 31, 2022 | -19,153.40 |
| Dec 31, 2021 | -3,101.63 |
| Sep 30, 2021 | -11,255.83 |
| Jun 30, 2021 | -11,181.80 |
| Mar 31, 2021 | -8,426.33 |
| Dec 31, 2020 | -7,807.00 |
| Sep 30, 2020 | -6,110.50 |
| Jun 30, 2020 | -4,463.17 |
| Mar 31, 2020 | -3,674.71 |
| Sep 30, 2019 | -6,366.00 |
| Jun 30, 2019 | -5,907.00 |
| Mar 31, 2019 | -2,115.00 |
| Dec 31, 2018 | -49.25 |
| Sep 30, 2018 | -5.93 |